Member of the Association of American Physicians
His scientific interests lie mostly in Immunology, CD8, Antigen, Cytotoxic T cell and T cell. His study in Immunotherapy, Chimeric antigen receptor, Adoptive cell transfer, CTL* and Cytokine release syndrome is done as part of Immunology. His work focuses on many connections between CD8 and other disciplines, such as Immunity, that overlap with his field of interest in FOXP3, Cytokine, Interleukin 15 and Herpesviridae.
His Antigen research includes themes of Immune system and T-cell receptor. His work investigates the relationship between Cytotoxic T cell and topics such as Virology that intersect with problems in In vivo and Genetic enhancement. His T cell research incorporates elements of Autoimmunity, Computational biology and B cell.
Stanley R. Riddell mainly focuses on Immunology, Antigen, Cytotoxic T cell, T cell and CD8. His research on Immunology often connects related topics like Transplantation. His Antigen study integrates concerns from other disciplines, such as Cancer research, Chimeric antigen receptor and T-cell receptor.
The study incorporates disciplines such as Molecular biology and Virology in addition to Cytotoxic T cell. His studies in CD8 integrate themes in fields like Cell and Immunity. His research investigates the connection between Immunotherapy and topics such as Cyclophosphamide that intersect with issues in Oncology.
Immunotherapy, Cancer research, Antigen, Chimeric antigen receptor and Internal medicine are his primary areas of study. His Immunotherapy study results in a more complete grasp of Immunology. His Cancer research study incorporates themes from Cancer and T cell, CD8, Immune system, CD19.
His CD8 research includes themes of Cytotoxic T cell and Cell. His Antigen research incorporates themes from In vivo, Tumor microenvironment, Tumor Escape, Adoptive cell transfer and Multiple myeloma. His studies deal with areas such as Cytokine, Antibody, B cell, Receptor and Cell biology as well as Chimeric antigen receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
Elizabeth A Walter;P. D. Greenberg;M. J. Gilbert;R. J. Finch.
The New England Journal of Medicine (1995)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells
C. Yee;J. A. Thompson;J. A. Thompson;D. Byrd;D. Byrd;S. R. Riddell;S. R. Riddell.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.
Stanley R. Riddell;Kathe S. Watanabe;James M. Goodrich;Cheng R. Li.
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
Veronika Groh;Rebecca Rhinehart;Julie Randolph-Habecker;Max S. Topp.
Nature Immunology (2001)
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Cameron J. Turtle;Laïla Aïcha Hanafi;Carolina Berger;Theodore A. Gooley.
Journal of Clinical Investigation (2016)
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan S. Robins;Paulo V. Campregher;Santosh K. Srivastava;Abigail Wacher.
Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.
Pierre Reusser;Stanley R. Riddell;Joel D. Meyers;Philip D. Greenberg.
T-cell Mediated Rejection of Gene-Modified HIV-specific Cytotoxic T Lymphocytes in HIV-infected Patients
Stanley R. Riddell;Mark Elliott;Deborah A. Lewinsohn;Mark J. Gilbert;Mark J. Gilbert.
Nature Medicine (1996)
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.
Carolina Berger;Michael C. Jensen;Peter M. Lansdorp;Mike Gough.
Journal of Clinical Investigation (2008)
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells
Cameron J. Turtle;Cameron J. Turtle;Laïla Aïcha Hanafi;Carolina Berger;Carolina Berger;Michael Hudecek.
Science Translational Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: